Edition:
United States

Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

10.65EUR
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
€10.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,205
52-wk High
€11.20
52-wk Low
€8.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 2 22.40 24.00 20.80 21.00
Year Ending Dec-18 2 31.25 36.00 26.50 34.50
Earnings (per share)
Year Ending Dec-17 2 -1.34 -1.00 -1.67 -1.76
Year Ending Dec-18 2 -0.81 -0.62 -1.00 -0.34
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.50 36.03
P/E High - Last 5 Yrs. -- 40.74 45.26
P/E Low - Last 5 Yrs. -- 23.65 24.26
Beta -- 0.92 0.91
Price to Sales (TTM) 13.62 3.97 5.90
Price to Book (MRQ) 3.65 4.92 5.74
Price to Tangible Book (MRQ) 23.07 5.79 7.33
Price to Cash Flow (TTM) -- 23.36 24.72
% Owned Institutions -- 0.85 1.38

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) -- 47.43 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 51.42 6.29 6.77
Sales (TTM) vs TTM 1 Yr. Ago 31.33 5.09 5.56
Sales - 5 Yr. Growth Rate -- 10.01 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 4.47 7.08 7.88
EPS (TTM) vs TTM 1 Yr. Ago -35.65 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.92
Capital Spending - 5 Yr. Growth Rate -- 15.14 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.80 2.49 2.55
Current Ratio (MRQ) 1.90 3.51 3.57
LT Debt to Equity (MRQ) 64.67 10.90 13.26
Total Debt to Equity (MRQ) 71.13 16.99 19.22
Interest Coverage (TTM) -3,621.75 49.07 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 45.32 55.21 54.87
Gross Margin - 5 Yr. Avg. -- 52.33 52.44
EBITD Margin (TTM) -138.61 -- --
EBITD - 5 Yr. Avg -- 18.52 15.70
Operating Margin (TTM) -145.23 14.76 6.77
Operating Margin - 5 Yr. Avg. -- 14.36 11.08
Pre-Tax Margin (TTM) -142.76 15.22 7.60
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 11.49
Net Profit Margin (TTM) -128.08 11.39 3.83
Net Profit Margin - 5 Yr. Avg. -- 11.00 7.78
Effective Tax Rate (TTM) -- 24.37 24.27
Effective Tax Rate - 5 Yr. Avg. -- 23.47 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 334,600 951,233,490 857,902,259
Net Income/Employee (TTM) -428,550 111,321,846 100,310,105
Receivable Turnover (TTM) 2.60 5.91 6.13
Inventory Turnover (TTM) 4.39 2.73 3.55
Asset Turnover (TTM) 0.14 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -17.30 11.90 11.35
Return on Assets - 5 Yr. Avg. -- 12.90 12.32
Return on Investment (TTM) -20.29 15.11 14.48
Return on Investment - 5 Yr. Avg. -- 16.87 16.13
Return on Equity (TTM) -32.94 16.59 16.06
Return on Equity - 5 Yr. Avg. -- 17.87 17.32
  1 Year 3 Year 5 Year
Sales % 9.95 8.32 --
EPS (TTM) % -191.57 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mithra Pharmaceuticals SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.55 2.72 99 61
13 Week 7.16 7.28 99 24
26 Week 16.39 13.58 99 33
52 Week 19.41 6.25 99 25
YTD 17.81 6.61 99 24
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.26%
# of Holders: 6
Total Shares Held: 5,567,070
3 Mo. Net Change: -86,295
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.